Long-Acting HIV Antiretroviral Therapy (ART): Cabotegravir/Rilpivirine (CAB/RPV)
This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine.
This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine.
This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing.
This information sheet provides guidance on covering the costs of PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis).
This journal examines the role of circular RNAs (circRNAs) in HIV-1 replication, highlighting the discovery that backsplicing of the HIV-1 transcript produces multiple circRNAs that enhance viral replication.
This journal discusses the development of a handheld platform designed for the detection of HIV, utilizing paper-based sample preparation and real-time isothermal amplification.
This journal presents findings from a pilot randomized clinical trial evaluating two brief interventions aimed at increasing HIV pre-exposure prophylaxis (PrEP) uptake among rural people who inject drugs (PWID) attending syringe services programs (SSPs) in Kentucky.
Contact organization for eligibility
Contact organization for eligibility
Contact organization for eligibility
This fact sheet serves as a conversation guide for patients about how to talk to healthcare providers about TB risk, understand the testing process, and discuss treatment options.